Table 4 Average count of tumor-infiltrating lymphocytes in relation to clinicopathologic features.
Gender | Location | LVI | Stage | Grade | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
F | M | P-value | R | L | P-value | Present | Absent | P-value | 1 | 2 | 3 | 4 | P-value | Low | High | P-value | |
Tumor infiltrating lymphocytes (average) | |||||||||||||||||
All cases | 64 | 49 | 0.06 | 78 | 40 | <0.0001 | 49 | 65 | 0.04 | 78 | 75 | 37 | 36 | <0.0001 | 47 | 90 | <0.0001 |
MSI | 135 | 192 | 0.1 | 205 | 154 | 0.4 | 163 | 143 | 0.6 | 206 | 152 | 127 | 95 | 0.5 | 118 | 191 | 0.02 |
MSS | 39 | 21 | 0.2 | 38 | 34 | 0.5 | 28 | 42 | 0.005 | 57 | 41 | 24 | 34 | <0.0001 | 35 | 28 | 0.3 |